Fintel reports that on November 10, 2025, Truist Securities maintained coverage of Evolent Health (NYSE:EVH) with a Buy recommendation. As of November 9, 2025, the average one-year price target for ...

Evolent Health (NYSE:EVH) priced $145M of 4.50% convertible senior notes due 2031, offered to qualified institutional buyers under Rule 144A. The deal size was raised from $140M, with an option for ...

Evolent Health (EVH) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.04 per share a year ago. These figures ...

The U.S. value-based care (VBC) service market is evolving rapidly, attracting investors for the prospect of long-term stability and compelling returns. Unlike traditional fee-for-service care, the ...